TheDose

Centella Asiatica Extract

Also known as Gotu Kola Extract, Centella Extract, CICA Extract

CIRPubMed

Safe

CIR Expert Panel says: safe as used in cosmetics.”

The CIR Expert Panel assessed nine Centella asiatica-derived ingredients, including Centella Asiatica Extract, as safe in current cosmetic use concentrations when formulated to be non-sensitizing (Final report 06/2015; re-reviewed in IJT 2023, PMID 36812692). The primary bioactive triterpenoids — asiaticoside and madecassoside — have documented anti-inflammatory, wound-healing, and collagen-stimulating properties across a broad body of in vitro and in vivo research (PMID 36756687). Sensitization potential is the primary safety concern, motivating the CIR's non-sensitizing formulation condition.


Anti-inflammatory activity via asiaticoside and madecassoside triterpenoids

Wound healing and skin regeneration — stimulates collagen synthesis and fibroblast migration

Antioxidant properties supporting UV-related skin protection

Barrier-reinforcing and soothing effects documented in sensitive skin clinical studies


Concerns
  • · Sensitization potential — CIR condition requires formulation to be non-sensitizing
  • · Cumulative sensitization risk when co-formulated with other botanical allergens (e.g., plants in Apiaceae/Umbelliferae family cross-reactors)

CIR Expert Panel
Approved
safe as used when formulated to be non-sensitizing
[1]
CIR Expert Panel · Jul 1, 2018Live

CIR Quick Reference Table (12/2017, revised 07/2018) — Centella Asiatica Extract row: Finding=SQ, Citation=Final report 06/2015 available…

Centella Asiatica Extract | SQ | safe as used when formulated to be non-sensitizing | Final report 06/2015 available from CIRQRT-122017revised072018.pdf, p. 22
Verificationpdf_textView source
[2]
Peer-reviewed (PubMed) · Feb 22, 2023

Safety Assessment of Centella asiatica-Derived Ingredients as Used in Cosmetics

Verificationweb_textView on PubMed
[3]
Peer-reviewed (PubMed) · Mar 1, 2023

Therapeutic properties and pharmacological activities of asiaticoside and madecassoside: A review

Verificationweb_textView on PubMed
Sources
3
PubMed citations
2
Evidence quality
moderate
Last verified
Re-reviewed when a new CIR / SCCS opinion publishes.